Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Industry partnership set to advance research on theranostics
The deal will create a Therapy Command Center to support the study and use of theranostics across Massachusetts General Hospital and its affiliated centers in bordering states.
SNMMI unveils its 2025 Image of the Year
The designation was awarded to a research team from China, who analyzed the efficacy of a novel radiotracer developed to target expression of the PD-L1 protein in suspected head and neck cancers.
3 industry partnerships, 1 clinical aim: Enriching the global supply chain of medical isotopes
Nuclear medicine operations may soon enjoy steadier flows of certain in-demand radioisotopes. If so, much credit will go to companies that had the strategic sense to collaborate with each other.
'Promising' new PET agent for brain metastases put on FDA's Fast Track
Clinical trial results thus far have been promising, representing a significant step forward for the hundreds of thousands of patients affected by brain metastases.
Ultrasound-guided thermal ablation safer, as effective as surgery for papillary thyroid cancer
Though surgery is the current standard of care, experts believe ablative strategies "may become the primary choice for PTC treatment" in the future.

Industry partnership set to advance research on theranostics

The deal will create a Therapy Command Center to support the study and use of theranostics across Massachusetts General Hospital and its affiliated centers in bordering states.

SNMMI unveils its 2025 Image of the Year

The designation was awarded to a research team from China, who analyzed the efficacy of a novel radiotracer developed to target expression of the PD-L1 protein in suspected head and neck cancers.

3 industry partnerships, 1 clinical aim: Enriching the global supply chain of medical isotopes

Nuclear medicine operations may soon enjoy steadier flows of certain in-demand radioisotopes. If so, much credit will go to companies that had the strategic sense to collaborate with each other.

'Promising' new PET agent for brain metastases put on FDA's Fast Track

Clinical trial results thus far have been promising, representing a significant step forward for the hundreds of thousands of patients affected by brain metastases.

Ultrasound-guided thermal ablation safer, as effective as surgery for papillary thyroid cancer

Though surgery is the current standard of care, experts believe ablative strategies "may become the primary choice for PTC treatment" in the future.

Earlier treatment with Pluvicto may be beneficial for patients with hormone-sensitive prostate cancer

The drug has shown a “clinically meaningful benefit” in these patients, suggesting its potential as an earlier treatment option than previously thought, Novartis reports.

Prostate cancer theranostic, said to match effectiveness of Pluvicto, heads to clinical trial

ART-101 is a prostate-specific membrane antigen-targeting small molecule that can pair with multiple isotopes, including actinium-225, lutetium-177 and terbium-161.

Hologic sees drop in sales and tariff impact on stock price

The vendor's latest earnings report outlines a nearly $35 million decline in mammography sales and projected ramifications from new tariffs.